View Older Stories

May 21, 2026 07:00AM Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin

May 19, 2026 12:09PM Sunshine Biopharma closes $6 million public offering with warrant potential

May 19, 2026 12:05PM Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering

May 18, 2026 12:18PM Sunshine Biopharma prices $6 million public offering at $0.50 per unit

May 18, 2026 12:15PM Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering

Apr 6, 2026 08:30AM Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year

Oct 28, 2025 02:10PM Sunshine Biopharma receives Health Canada approval for domperidone marketing

Oct 28, 2025 02:10PM Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)

Oct 28, 2025 07:45AM Sunshine Biopharma receives Health Canada approval for domperidone

Oct 28, 2025 07:45AM Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea

Oct 20, 2025 07:45AM Sunshine Biopharma launches generic doxycycline in Canada

Oct 20, 2025 07:45AM Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline

Oct 16, 2025 07:45AM Sunshine Biopharma launches generic cholesterol drug pravastatin in Canada

Oct 16, 2025 07:45AM Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin

Oct 14, 2025 10:45AM Sunshine Biopharma is Proving That Riding Momentum is an Effective Strategy (NASDAQ:SBFM)

Oct 14, 2025 08:50AM Sunshine Biopharma Proves Microcap Ambition Can Deliver Large-Cap Level Execution (NASDAQ: SBFM)

Oct 14, 2025 07:03AM Sunshine Biopharma allocates $5 million for bitcoin investment

Oct 14, 2025 07:00AM Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience

Oct 9, 2025 08:02AM Sunshine Biopharma develops new coronavirus protease inhibitors

Oct 9, 2025 08:00AM Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections

Aug 5, 2025 06:04AM Sunshine Biopharma, Inc. (SBFM) Files for 15.58M Share Offering by Selling Stockholders

Jul 2, 2025 08:02AM Sunshine Biopharma, Inc. (SBFM) Launches NIOPEG

Jul 2, 2025 08:00AM Sunshine Biopharma Launches NIOPEG(R) Into $10 Billion Biologics Market

Jun 11, 2025 08:34AM Sunshine Biopharma (SBFM) Launches Generic Gabapentin for Neuropathic Pain

Jun 11, 2025 08:30AM Sunshine Biopharma Launches Generic Gabapentin for Neuropathic Pain in the Canadian Segment of the Global $1.92 Billion Market

May 15, 2025 04:15PM Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last Year

May 6, 2025 08:32AM Sunshine Biopharma, Inc. (SBFM) launches Lurasidone in Canada

May 6, 2025 08:30AM Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion Market

Apr 21, 2025 08:32AM Sunshine Biopharma (SBFM) Launches Everolimus In Canada

Apr 21, 2025 08:30AM Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion

Apr 3, 2025 10:50AM Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering

Apr 2, 2025 01:22PM Sunshine Biopharma (SBFM) Announces $2.46 Million Registered Direct Offering of Common Stock, Warrants

Apr 2, 2025 01:20PM Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules

Apr 2, 2025 08:04AM Sunshine Biopharma, Inc. (SBFM) Announces Positive Results of mRNA Therapy for Cancer

Apr 2, 2025 08:00AM Sunshine Biopharma Announces Positive Results of mRNA Therapy for Cancer

Apr 1, 2025 05:09PM Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year

Mar 24, 2025 08:02AM Sunshine Biopharma, Inc. (SBFM) Acquires Marketing Rights for Two New Antibiotics in Canada

Mar 24, 2025 08:00AM Sunshine Biopharma Expands Presence in the $53.9 Billion Global Antibiotics Market with the Acquisition of Marketing Rights for Two New Antibiotics in Canada

Mar 10, 2025 09:02AM Sunshine Biopharma, Inc. (SBFM) Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian Market

Mar 10, 2025 09:00AM Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market

Jan 21, 2025 08:04AM Sunshine Biopharma (SBFM) Expands Its Product Line to 69 Generic Prescription Drugs

Jan 21, 2025 08:00AM Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT

Jan 15, 2025 08:03AM Sunshine Biopharma, Inc. (SBFM) Appoints Michel Roy as Chief Commercial Officer

Jan 15, 2025 08:00AM Sunshine Biopharma Announces the Appointment of New Chief Commercial Officer

Jan 6, 2025 11:47AM Sunshine Biopharma, Inc. (SBFM) Files $100M Mixed Shelf

Dec 9, 2024 07:30AM Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus

Nov 22, 2024 08:05AM Sunshine Biopharma SBFM) Launches a New Generic Prescription Drug

Nov 22, 2024 08:00AM Sunshine Biopharma Launches a New Generic Prescription Drug

Nov 6, 2024 08:00AM Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54%

Sep 26, 2024 08:03AM Sunshine Biopharma (SBFM) Launches Two New Generic Prescription Drugs

View Older Stories